Butalbital/aspirin/caffeine

Jump to navigation Jump to search
Butalbital/aspirin/caffeine
BUTALBITAL, ASPIRIN AND CAFFEINE TABLETS bultabital, aspirin and caffeine tablet ® FDA Package Insert
Indications and Usage
Dosage and Administration
Dosage Forms and Strengths
Contraindications
Warnings and Precautions
Adverse Reactions
Drug Interactions
Use in Specific Populations
Overdosage
Description
Clinical Pharmacology
Nonclinical Toxicology
Clinical Studies
How Supplied/Storage and Handling
Patient Counseling Information
Labels and Packages
Clinical Trials on Butalbital/aspirin/caffeine
ClinicalTrials.gov

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Pratik Bahekar, MBBS [2]

For patient information about Butalbital/aspirin/caffeine, click here.

Synonyms / Brand Names: ®,

Overview

Category

FDA Package Insert

Indications and Usage | Dosage and Administration | Dosage Forms and Strengths | Contraindications | Warnings and Precautions | Adverse Reactions | Drug Interactions | Use in Specific Populations | Overdosage | Description | Clinical Pharmacology | Nonclinical Toxicology | Clinical Studies | How Supplied/Storage and Handling | Patient Counseling Information | Labels and Packages

Mechanism of Action

[1]

References

  1. "ALAGESIC LQ (BUTALBITAL, ACETAMINOPHEN AND CAFFEINE) SYRUP [POLY PHARMACEUTICALS, INC.]".

Antimigraine preparations